Dry Eye Disease: Advancing Science on Emerging Novel Treatments and Delivery Systems

Author(s)/Faculty: Terry Kim, MD; Marjan Farid, MD; Francis S. Mah, MD
Release Date: 2/23/2022Expiration Date: 2/22/2023
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.75
Content Type: LectureProvider:
Dry eye disease (DED) is a prevalent but frequently underdiagnosed and undertreated condition that has a significant impact on quality of life, work, and daily activities. It can also adversely affect outcomes from ocular surgery. As our understanding of the risk factors and underlying mechanisms of DED has increased, treatment options have expanded considerably. Clinicians must recognize the patients who are at risk for significant disease and which of the available therapies are best suited to their needs. In this educational activity, faculty discuss the burden and risk factors of DED and assess the mechanisms of action, efficacy, and safety of new and emerging treatment options for this disorder. Experts also review clinical cases to highlight best practices for integrating novel mechanisms of action into existing treatment paradigms.